A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
N Engl J Med. 2012 Mar 1;366(9):799-807. doi: 10.1056/NEJMoa1110557.
N Engl J Med. 2012.
PMID: 22375971
Free PMC article.
Clinical Trial.